| Ambrisentan |
| Amondys 45 |
| Amphetamines NCSHP C10388 C 11 2019 |
| Amphetamines NCSHP C10388 C 11 2019 |
| Ampyra |
| Anadrol-50 |
| Androderm |
| Androgel |
| Android |
| Androxy |
| Antidiabetic GLP-1 Agonist Limit |
| Antiemetic 5 HT3 Post Limit Policy 16 J 01 2020a |
| Antiemetic 5 HT3 Post Limit Policy 16 J 01 2020b |
| Antiemetic 5 HT3 Post Limit Policy 16 J 01 2020b |
| Antiemetic 5 HT3 Post Limit Policy 16 J 01 2020b |
| Antiemetic 5 HT3 Post Limit Policy 16 J 01 2020b |
| Antiemetic 5 HT3 Post Limit Policy 16 J 01 2020b |
| Antiobesity Agents |
| Anzemet Limit Policy 19 H 01 2019 |
| Apexicon E (Brand Only) |
